by Anita Santos | Sep 10, 2020 | Press Releases
LabMinds Helps Waters Corporation Enhance Automation and Efficiency of Lab Operations Across Multiple Locations Waters deploying LabMinds’ REVO solution at research labs in the U.S. and Europe September 10, 2020 07:37 AM Eastern Daylight Time BOSTON–(BUSINESS...
by Anita Santos | Jun 2, 2020 | Press Releases
LabMinds Secures Financing to Boost Commercial Growth of The REVO® Robotic System LabMinds adding value to customers’ COVID-19 drug discovery and development BOSTON–(BUSINESS WIRE)–LabMinds, Inc., an award-winning robotics company in life sciences, today...
by Jennifer O'Neill | Apr 27, 2020 | Press Releases
LabMinds Appoints Jeff Caputo Chief Executive Officer Boston, MA: LabMinds, Inc., a next-generation robotics company focused on solution preparation, announces that Jeff Caputo has been named as President and Chief Executive Officer and a Member of the Board of...
by Anita Santos | Feb 12, 2020 | Press Releases, Recognition
Revo Finalist in “Innovative Services – AI Applications” 2020 Edison Awards’s Category For Immediate Release Somerville, MA – 02/12/2020 – LabMinds’ Revo has been named a finalist in the “Innovative Services – AI Applications” category for the 2020 Edison...
by Anita Santos | Oct 3, 2019 | Other News
The Impact of Artificial Intelligence (AI) on Drug Discovery From meeting challenges in solution prep to more ‘flashy’ analysis of the interaction between drugs, humans, and their contexts, we learn about the mounting importance of AI in drug discovery...
